We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+0.21%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$296M
AUM Growth
-$4.31M
Cap. Flow
+$86.6K
Cap. Flow %
0.03%
Top 10 Hldgs %
47.38%
Holding
588
New
23
Increased
63
Reduced
57
Closed
32

Top Buys

Rank Stock Value
1
ABUS icon
Arbutus Biopharma
ABUS
+$437K
2
MSFT icon
Microsoft
MSFT
+$207K
3
IWD icon
iShares Russell 1000 Value ETF
IWD
+$117K
4
COWZ icon
Pacer US Cash Cows 100 ETF
COWZ
+$82.4K
5
VUG icon
Vanguard Growth ETF
VUG
+$74.7K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$466K
2
AAPL icon
Apple
AAPL
+$212K
3
AVGO icon
Broadcom
AVGO
+$171K
4
GTLS
Chart Industries
GTLS
+$155K
5
FTSM icon
First Trust Enhanced Short Maturity ETF
FTSM
+$132K

Sector Composition

Rank Sector Weight
1 Technology 52.09%
2 Healthcare 7.88%
3 Consumer Staples 6.24%
4 Industrials 5.95%
5 Financials 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
501
Regeneron Pharmaceuticals
REGN
$68.3B
$1.54K ﹤0.01%
2
– –
ALK icon
502
Alaska Air
ALK
$4.94B
$1.54K ﹤0.01%
42
– –
BAX icon
503
Baxter International
BAX
$11.2B
$1.51K ﹤0.01%
90
– –
EVR icon
504
Evercore
EVR
$13B
$1.49K ﹤0.01%
+5
New +$1.64K
SPOT icon
505
Spotify
SPOT
$97.5B
$1.46K ﹤0.01%
+3
New +$1.51K
ARKW icon
506
ARK Web x.0 ETF
ARKW
$1.72B
$1.45K ﹤0.01%
12
– –
HYLB icon
507
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.53B
$1.45K ﹤0.01%
40
– –
SOLV icon
508
Solventum
SOLV
$13.4B
$1.44K ﹤0.01%
22
– –
BGS icon
509
B&G Foods
BGS
$291M
$1.43K ﹤0.01%
286
– –
GEHC icon
510
GE HealthCare
GEHC
$27.9B
$1.42K ﹤0.01%
20
– –
RGEN icon
511
Repligen
RGEN
$7.9B
$1.41K ﹤0.01%
12
– –
AWK icon
512
American Water Works
AWK
$26.1B
$1.36K ﹤0.01%
10
– –
MPT
513
Medical Properties Trust
MPT
$2.88B
$1.18K ﹤0.01%
250
– –
FVD icon
514
First Trust Value Line Dividend Fund
FVD
$8.18B
$1.18K ﹤0.01%
25
– –
DON icon
515
WisdomTree US MidCap Dividend Fund
DON
$4.02B
$1.1K ﹤0.01%
21
– –
TAK icon
516
Takeda Pharmaceutical
TAK
$53.9B
$1.06K ﹤0.01%
57
– –
LNTH icon
517
Lantheus
LNTH
$6.81B
$986 ﹤0.01%
13
– –
XPH icon
518
State Street SPDR S&P Pharmaceuticals ETF
XPH
$470M
$978 ﹤0.01%
18
– –
VT icon
519
Vanguard Total World Stock ETF
VT
$77.2B
$968 ﹤0.01%
7
– –
MTUM icon
520
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
$960 ﹤0.01%
4
– –
SQQQ icon
521
ProShares UltraPro Short QQQ
SQQQ
$2.02B
$644 ﹤0.01%
8
– –
PSCU icon
522
Invesco S&P SmallCap Utilities & Communication Services ETF
PSCU
$17.4M
$602 ﹤0.01%
10
– –
EFV icon
523
iShares MSCI EAFE Value ETF
EFV
$27.7B
$595 ﹤0.01%
8
– –
ULTA icon
524
Ulta Beauty
ULTA
$20.8B
$523 ﹤0.01%
1
– –
VOD icon
525
Vodafone
VOD
$35.7B
$496 ﹤0.01%
33
– –
19 20
21
22 23

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
KNFPWM
Keeler & Nadler Financial Planning & Wealth Management Dublin, Ohio $295M AUM 18.48% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return

Front Row Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Front Row Advisors held 588 positions worth $296M, down 1.4% from $300M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Front Row Advisors's Q1 2026 filing shows 23 new, 63 increased, 57 reduced and 32 closed positions. Its largest new stake was Blackstone: 500 shares worth $57.5K. The largest sale was NVIDIA, an estimated $466K.

By sector, the portfolio is most concentrated in Technology at 52% of assets, down from 53% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Front Row Advisors's largest Q1 2026 buy was Blackstone: 500 shares worth $57.5K.
  • Front Row Advisors added most to Arbutus Biopharma in Q1 2026, an estimated $437K increase.
  • Front Row Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $466K.
  • Front Row Advisors fully exited Confluent in Q1 2026, selling an estimated $24.2K.
  • Front Row Advisors's ten largest holdings make up 47% of its $296M portfolio in Q1 2026.
  • Front Row Advisors opened 23 new positions and closed 32 in Q1 2026.
  • Front Row Advisors's portfolio value fell 1.4% quarter-over-quarter to $296M.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.